Dissolved and financials
CVR: 37104469
DKK 2,803,867
Gross profit
Net result: DKK -27,225
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 2 September 2020
CVR · view overview
1 employee
CVR · 2018
Director role ended: Sandipkumar Shantilal Kapadia
CVR · 02/09/2020
View the full event history
Intercept Pharma Danmark ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company has been dissolved on 2 September 2020. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 2,803,867 and a net result of DKK -27,225 compared with DKK -7,148,070 the year before. Equity in the 2019 report amounted to DKK -38,893,973.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201901/01/2019 – 31/12/2019 | 2.8 mio. | -27 t. | 9.7 mio. | -38.9 mio. | 1 | |
| 201801/01/2018 – 31/12/2018 | 1.1 mio. | -7.1 mio. | 8.4 mio. | -38.9 mio. | 5 | |
| 201701/01/2017 – 31/12/2017 | -9.2 mio. | -25.8 mio. | 6.9 mio. | -31.7 mio. | 5 |
Compared to 404 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. Intercept Pharma Danmark ApS is registered in the Danish CVR register with the status Dissolved and ceased on 2 September 2020.
The CVR number of Intercept Pharma Danmark ApS is 37104469.
In 2019, Intercept Pharma Danmark ApS reported a gross profit of DKK 2,803,867.
Intercept Pharma Danmark ApS had 1 employee in 2018 according to the Danish CVR register.
Intercept Pharma Danmark ApS was founded on 23 September 2015.
Intercept Pharma Danmark ApS was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
As of September 2, 2020, Sandipkumar Shantilal Kapadia has stepped down as director of Intercept Pharma Danmark ApS.
Intercept Pharma Danmark ApS was dissolved on September 2, 2020.
As of July 3, 2020, Daniel Hood has stepped down as director of Intercept Pharma Danmark ApS.
Intercept Pharma Danmark ApS has published its annual report for 2019. Gross profit came to DKK 2,803,867, and the net result was DKK -27,225.
Intercept Pharma Danmark ApS has published its annual report for 2018. Gross profit came to DKK 1,052,615, and the net result was DKK -7,148,070.
Intercept Pharma Danmark ApS has published its annual report for 2017. Gross profit came to DKK -9,176,767, and the net result was DKK -25,789,009.
As of January 11, 2018, Daniel Hood is registered as director of Intercept Pharma Danmark ApS.
As of December 31, 2017, Seokho Bryan Yoon has stepped down as director of Intercept Pharma Danmark ApS.
As of December 31, 2017, Gülizar Aybasti Skjoldager has stepped down as director of Intercept Pharma Danmark ApS.
Intercept Pharma Danmark ApS has published its interim report for the period September 23, 2015 to December 31, 2016.
As of May 30, 2017, Sandipkumar Shantilal Kapadia is registered as director of Intercept Pharma Danmark ApS.
As of May 30, 2017, Barbara Duncan has stepped down as director of Intercept Pharma Danmark ApS.
As of September 23, 2015, Seokho Bryan Yoon is registered as director of Intercept Pharma Danmark ApS.
As of September 23, 2015, Barbara Duncan is registered as director of Intercept Pharma Danmark ApS.
As of September 23, 2015, Gülizar Aybasti Skjoldager is registered as director of Intercept Pharma Danmark ApS.
Intercept Pharma Danmark ApS was founded on September 23, 2015.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 46788176
CVR 45929698
CVR 19064301
CVR 37726508
CVR 44420449
